The present invention is directed to radiolabeled neuropeptide Y Y5 receptor antagonists which are useful for the labeling and diagnostic imaging of neuropeptide Y Y5 receptors in mammals.

 
Web www.patentalert.com

< Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

< Inhibition of irritating side effects associated with use of a topical ophthalmic medication

> Cholesterol lowering supplement

> Therapeutic agent for amyotrophic lateral sclerosis (ALS)
~ 00205